PATENT CLAIM ANALYSIS

Application Number: 15944581
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "450000"]

Abstract:
A liposome formulation for delivery of Wnt signal pathway inhibitor is provided herein, which comprises lipid molecules and Wnt signal pathway inhibitor, wherein the liposome formulation is prepared through following steps: (1) providing an aqueous solution of the Wnt signal pathway inhibitor and providing an alcoholic solution of the lipid molecules, (2) mixing the aqueous solution of the Wnt signal pathway inhibitor and the alcoholic solution of the lipid molecules, (3) removing alcohol solvent to obtain the liposome formulation with Wnt signal pathway inhibitor encapsulated therein.

Claim (Index 5):
The liposome formulation of  claim 3 , wherein the Wnt signal pathway inhibitor encapsulated within the liposome formulation has a concentration between 0.5 mg/ml and 500 mg/ml, or 0.5 mg/ml and 50 mg/ml, or 0.5 mg/ml and 5 mg/ml, or 0.5 mg/ml and 1.5 mg/ml.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 2.13043
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14171151', '13057473', '15300688', '14774212', '11371586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.692616093891862
- 35 USC 102 Novelty (BERT): 0.5006166015528732
- Combined Prediction Score: 0.6734161446579632
- Mean Citation Score: 216.347908
- Max Citation Score: 222.1215
- Similarity Product: 158.44618790665268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test